BioSmart Co.Ltd (038460) — Cash Flow Reinvestment Rate
BioSmart Co.Ltd (038460) has a Cash Flow Reinvestment Rate of 0.54x as of September 2025, reinvesting ₩4.12 Billion (capex ₩1.22 Billion plus investments ₩2.90 Billion) from operating cash flow of ₩7.59 Billion. See how much free cash does BioSmart Co.Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
BioSmart Co.Ltd Cash Flow Reinvestment Rate (2010–2024)
Historical reinvestment intensity for BioSmart Co.Ltd across 9 annual periods. For the full cash flow conversion analysis, see 038460 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for BioSmart Co.Ltd (2010–2024)
Year-by-year capital reinvestment analysis for BioSmart Co.Ltd. See BioSmart Co.Ltd (038460) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.60x | ₩17.49 Billion | ₩3.80 Billion | ₩8.66 Billion | ▼ -61.0% |
| 2023 | 11.80x | ₩13.75 Billion | ₩1.17 Billion | ₩4.92 Billion | ▲ +469.2% |
| 2022 | 2.07x | ₩11.58 Billion | ₩5.59 Billion | ₩5.87 Billion | ▼ -60.9% |
| 2021 | 5.30x | ₩6.37 Billion | ₩1.20 Billion | ₩5.22 Billion | ▲ +599.2% |
| 2018 | 0.76x | ₩4.41 Billion | ₩5.81 Billion | ₩3.34 Billion | ▼ -68.1% |
| 2014 | 2.37x | ₩3.10 Billion | ₩1.31 Billion | ₩927.27 Million | ▲ +1120.7% |
| 2013 | 0.19x | ₩748.17 Million | ₩3.85 Billion | ₩748.17 Million | ▲ +87.0% |
| 2012 | 0.10x | ₩895.45 Million | ₩8.62 Billion | ₩895.45 Million | ▼ -16.0% |
| 2010 | 0.12x | ₩589.05 Million | ₩4.76 Billion | ₩589.05 Million | — |